drugset / Trial / NCT06285240
Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia Taking Stable Donepezil Treatment (MK-1167-007)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The main purpose of this study is to assess the safety and efficacy of MK-1167 administered to participants with Alzheimer's Disease (AD) receiving stable Donepezil treatment.
Timeline
- Start
- 2024-03-28
- Primary completion
- 2024-09-23
- Completion
- 2024-09-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MK-1167 | Unknown | 3 mg | Oral |
| Subject | MK-1167 | Unknown | 6 mg | Oral |
| Background | Donepezil | Small molecule | 10 mg | Oral |